These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37385921)

  • 21. Phylogenomics of phosphoinositide lipid kinases: perspectives on the evolution of second messenger signaling and drug discovery.
    Brown JR; Auger KR
    BMC Evol Biol; 2011 Jan; 11():4. PubMed ID: 21208444
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exploring Polypharmacology in Drug Discovery and Repurposing Using the CANDO Platform.
    Chopra G; Samudrala R
    Curr Pharm Des; 2016; 22(21):3109-23. PubMed ID: 27013226
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polypharmacology in Drug Discovery: A Review from Systems Pharmacology Perspective.
    Zhang W; Bai Y; Wang Y; Xiao W
    Curr Pharm Des; 2016; 22(21):3171-81. PubMed ID: 26907941
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasmodium dihydroorotate dehydrogenase: a promising target for novel anti-malarial chemotherapy.
    Phillips MA; Rathod PK
    Infect Disord Drug Targets; 2010 Jun; 10(3):226-39. PubMed ID: 20334617
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exploring novel targets for antimalarial drug discovery: plasmodial protein kinases.
    Jirage D; Keenan SM; Waters NC
    Infect Disord Drug Targets; 2010 Jun; 10(3):134-46. PubMed ID: 20334624
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The resistome and genomic reconnaissance in the age of malaria elimination.
    Kümpornsin K; Kochakarn T; Chookajorn T
    Dis Model Mech; 2019 Dec; 12(12):. PubMed ID: 31874839
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting the active sites of malarial proteases for antimalarial drug discovery: approaches, progress and challenges.
    Roy KK
    Int J Antimicrob Agents; 2017 Sep; 50(3):287-302. PubMed ID: 28668681
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antimalarial drug discovery: targeting protein kinases.
    Doerig C; Meijer L
    Expert Opin Ther Targets; 2007 Mar; 11(3):279-90. PubMed ID: 17298288
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. (+)-SJ733, a clinical candidate for malaria that acts through ATP4 to induce rapid host-mediated clearance of Plasmodium.
    Jiménez-Díaz MB; Ebert D; Salinas Y; Pradhan A; Lehane AM; Myrand-Lapierre ME; O'Loughlin KG; Shackleford DM; Justino de Almeida M; Carrillo AK; Clark JA; Dennis AS; Diep J; Deng X; Duffy S; Endsley AN; Fedewa G; Guiguemde WA; Gómez MG; Holbrook G; Horst J; Kim CC; Liu J; Lee MC; Matheny A; Martínez MS; Miller G; Rodríguez-Alejandre A; Sanz L; Sigal M; Spillman NJ; Stein PD; Wang Z; Zhu F; Waterson D; Knapp S; Shelat A; Avery VM; Fidock DA; Gamo FJ; Charman SA; Mirsalis JC; Ma H; Ferrer S; Kirk K; Angulo-Barturen I; Kyle DE; DeRisi JL; Floyd DM; Guy RK
    Proc Natl Acad Sci U S A; 2014 Dec; 111(50):E5455-62. PubMed ID: 25453091
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discovery of FNDR-20123, a histone deacetylase inhibitor for the treatment of Plasmodium falciparum malaria.
    Potluri V; Shandil RK; Gavara R; Sambasivam G; Campo B; Wittlin S; Narayanan S
    Malar J; 2020 Oct; 19(1):365. PubMed ID: 33046062
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Advances in Drug Discovery based on Genomics, Proteomics and Bioinformatics in Malaria.
    Aggarwal S; Karmakar A; Krishnakumar S; Paul U; Singh A; Banerjee N; Laha N; Roy Ball G; Srivastava S
    Curr Top Med Chem; 2023; 23(7):551-578. PubMed ID: 37073654
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An integrated virtual screening and drug repurposing strategy for the discovery of new antimalarial drugs against Plasmodium falciparum phosphatidylinositol 3-kinase.
    Verma K; Lahariya AK; Dubey S; Verma AK; Das A; Schneider KA; Bharti PK
    J Cell Biochem; 2021 Oct; 122(10):1326-1336. PubMed ID: 33998049
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessing protein kinase target similarity: Comparing sequence, structure, and cheminformatics approaches.
    Gani OA; Thakkar B; Narayanan D; Alam KA; Kyomuhendo P; Rothweiler U; Tello-Franco V; Engh RA
    Biochim Biophys Acta; 2015 Oct; 1854(10 Pt B):1605-16. PubMed ID: 26001898
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insights into Integrated Lead Generation and Target Identification in Malaria and Tuberculosis Drug Discovery.
    Okombo J; Chibale K
    Acc Chem Res; 2017 Jul; 50(7):1606-1616. PubMed ID: 28636311
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Harnessing systematic protein-ligand interaction fingerprints for drug discovery.
    Zhao Z; Bourne PE
    Drug Discov Today; 2022 Oct; 27(10):103319. PubMed ID: 35850431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efforts Aimed To Reduce Attrition in Antimalarial Drug Discovery: A Systematic Evaluation of the Current Antimalarial Targets Portfolio.
    Chaparro MJ; Calderón F; Castañeda P; Fernández-Alvaro E; Gabarró R; Gamo FJ; Gómez-Lorenzo MG; Martín J; Fernández E
    ACS Infect Dis; 2018 Apr; 4(4):568-576. PubMed ID: 29320160
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of the Antimalarial MMV390048 against
    Ji S; Galon EM; Rizk MA; Yi Y; Zafar I; Li H; Ma Z; Iguchi A; Asada M; Liu M; Xuan X
    Antimicrob Agents Chemother; 2022 Sep; 66(9):e0057422. PubMed ID: 35924942
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exploiting polypharmacology for improving therapeutic outcome of kinase inhibitors (KIs): An update of recent medicinal chemistry efforts.
    Ma X; Lv X; Zhang J
    Eur J Med Chem; 2018 Jan; 143():449-463. PubMed ID: 29202407
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plerixafor and related macrocyclic amines are potential drug candidates in treatment of malaria by "filling the flap" region of plasmepsin enzymes.
    Abiri A
    Med Hypotheses; 2018 Sep; 118():68-73. PubMed ID: 30037618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.